BLOOMIOS, INC.
company.status.inactiveCIK 1138608fmd_193QB8SS3SN1S44M4KRFMW2RFBManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2018 to Sep 30, 2023, 28 periods
| Line item | FY2018 | FY2019 | FY2019 | FY2020 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | 0 | – | – | 1 | 8 | 6 |
| Cost of revenue | – | 0 | – | – | 1 | 5 | 4 |
| Gross profit | – | – | 0 | – | 0 | 4 | 2 |
| Selling, general and administrative | – | – | 0 | – | 0 | 1 | 2 |
| Total operating expenses | – | – | 0 | – | 1 | 5 | 6 |
| Operating income | – | – | (0) | – | (1) | (1) | (4) |
| Interest expense | – | – | 0 | – | 0 | 0 | 1 |
| Other non-operating income (expense) | – | 0 | – | 0 | – | – | – |
| Income before taxes | – | – | (0) | – | (1) | (2) | (14) |
| Income tax expense | – | – | 0 | – | 0 | 0 | 0 |
| Net income from continuing operations | – | – | (0) | – | (1) | (2) | (14) |
| Net income | (0) | – | (0) | – | (1) | (2) | (14) |